Cognitive function Nervous System Diseases
Conditions
Interventions
Screening: Potential study participants will undergo a phone screening using the study phone script to determine general eligibility. If they pass this initial screening, they will be invited to a fam
Sponsors
WoodNext Foundation
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Must have the ability to complete the study, comply with the study procedures, consume the investigational product daily for the duration of the study, and provide voluntary written informed consent in English (i.e., English literacy) to participate in the study 2. Must have the ability to refrain from alcohol intake and ingesting caffeinated foods and beverages (chocolate, coffee, tea, energy drinks, etc.) 48-hours prior to each testing session 3. Must agree to abstain from dietary supplements (e.g., caffeine, gingko biloba, ashwagandha, paraxanthine, arginine, etc.) that may affect cognitive function during the study 4. Must have the ability to complete and understand the cognitive function practice tests in English (i.e., English literacy)
Exclusion criteria
Exclusion criteria: 1. Known vitamin B12/B6 or folate deficiency 2. Known homocystinuria (a rare inherited metabolic disorder that prevents the body from processing the amino acid methionine) 3. High homocysteine levels (> 50 µmol/L) 4. A history of kidney disease requiring dialysis 5. Diagnosed with a cognitive impairment or neurological disease (e.g., Alzheimer’s disease, Parkinson’s disease, etc.) 6. Pregnant (confirmed via a negative pregnancy test for all female participants), breastfeeding, or wishing to become pregnant during the study 7. Uncontrolled heart disease, hypertension, diabetes, thyroid disease, cancer, neurological disease or medically treated major psychological or depressive disorder that may affect results of the study 8. A known allergy or are you sensitive to meat or fish (containing GAA and Cr) or any of the ingredients in the supplement products (GAA, Cr, Omega-3 fatty acids, curcumin, citicoline, and maltodextrin placebo) 9. Additional conditions which, in the PI’s opinion, may adversely affect your ability to complete the study, its measurements, or pose a significant risk
Countries
United States of America
Contacts
Public ContactChristopher Rasmussen
Outcome results
None listed